Clinical Trial Update: Impact of Pre-operative Bevacizumab on Complications After Resection of Colorectal Liver Metastases

View source ↗

Summary

A clinical trial assessing whether pre-operative bevacizumab influences complications after surgical resection of colorectal liver metastases has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Liver Metastases

Drugs mentioned

• Bevacizumab (bevacizumab)

Snippet

Sponsor: University of Zurich | Conditions: Colorectal Liver Metastases | Status: COMPLETED